Sorted By:

Relevance


Clinical Pathways: Overview of Current Practices and Potential Implications for Patients, Payers, and Providers

PhRMA  |  Report

In response to a greater emphasis on paying for value in healthcare, payers and providers are also beginning to link financial incentives to compliance with pathway recommendations and achievement of improved patient outcomes.
https://www.phrma.org

Medicare Monday: Adherence in Medicare and Medicaid saves money

PhRMA  |  Blog Post

Learn more about adherence in our Ask About Adherence series here and continue following Medicare Monday here.
http://catalyst.phrma.org/medicare-monday-adherence-in-medicare-and-medicaid-saves-money

Consumers Still Pay Bigger Share For Healthcare Than Government And Businesses

Access Better Coverage  |  From Our Network

And 23% of income for the median household was needed to pay premiums for family coverage in 2013, up from 21% in 2010.
http://www.accessbettercoverage.org/social-news/consumers-still-pay-bigger-share-for-healthcare-than-government-and-businesses

PPA connects nearly 10 million people; Celebrates 11th anniversary and launches mobile app

PhRMA  |  Blog Post

YouTube, and follow us on Facebook and Twitter.
http://catalyst.phrma.org/ppa-celebrates-11th-anniversary-and-launches-mobile-app

Partnership for Prescription Assistance Relaunches Website with New Features for Patients and Caregivers

PhRMA  |  Press Release

Our mission is to increase awareness of patient assistance programs and boost enrollment of those who are eligible.
https://www.phrma.org/press-release/partnership-for-prescription-assistance-relaunches-website-with-new-features-for-patients-and-caregivers

Rotary International and PhRMA team up for “The World’s Biggest Commercial”

PhRMA  |  Press Release

About PhRMA The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research and biotechnology companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives.
https://www.phrma.org/press-release/rotary-international-and-phrma-team-up-for-the-world-s-biggest-commercial

A critical opportunity to prevent prescription drug abuse

PhRMA  |  Blog Post

This is an opportunity to collectively work together to support ongoing educational efforts so the public, patients, caregivers and others understand the dangers of prescription drug abuse and the role they can play in reducing the potential for abuse and misuse.
http://catalyst.phrma.org/a-critical-opportunity-to-prevent-prescription-drug-abuse

Ask About Adherence: Q&A with The Peter Lamy Center for Drug Therapy and Aging

PhRMA  |  Blog Post

  In the end we selected variables in five domains: socioeconomic characteristics, self-reported health, use of preventive services, diabetes knowledge and behaviors, and adherence to other chronic medications.
http://catalyst.phrma.org/ask-about-adherence-qa-with-the-peter-lamy-center-for-drug-therapy-and-aging

PhRMA Statement on Rx Response’s Pharmacy Status Reporting Tool Activation in 11 States and the District of Columbia

PhRMA  |  Press Release

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research and biotechnology companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives.
https://www.phrma.org/press-release/phrma-statement-on-rx-response-s-pharmacy-status-reporting-tool-activation-in-11-states-and-the-district-of-columbia

New PhRMA Report: 836 medicines and vaccines in development to treat cancers

PhRMA  |  Blog Post

To celebrate the progress and promise of oncology research and care, PhRMA honored oncology researchers and patient advocates yesterday at the 2015 Research & Hope Awards in Washington, D.C..
http://catalyst.phrma.org/new-phrma-report-836-medicines-and-vaccines-in-development-to-treat-cancers

Guest Contributor: Debra of America on Epidermolysis Bullosa

PhRMA  |  Blog Post

She fought for all those with disabilities and that is inspirational. 
http://catalyst.phrma.org/guest-contributor-debra-of-america-on-epidermolysis-bullosa

Biopharmaceutical Research Companies Play a Pivotal Role in Drug Discovery and Development

Chartpack  |  From Our Network

Recent studies show that biopharmaceutical companies perform the vast majority of development work to bring new medicines to patients.   ...
http://chartpack.phrma.org/biophrma-chartpack/research-and-development/biopharmaceutical-research-companies-play-a-pivotal-role-in-drug-discovery-and-development

Key U.S. Health Industries Outline Six-Point Plan for Improved Health and Economic Growth in Asia-Pacific Region

PhRMA  |  Press Release

  In addition to endorsing the plan, the CEO’s of two major U.S. health care companies, Johnson and Johnson and Eli Lilly and Company, also congratulated APEC members on their progress to address Non-Communicable Diseases (NCDs) and achieve regulatory convergence, both components of the overall plan.
https://www.phrma.org/press-release/key-u-s-health-industries-outline-six-point-plan-for-improved-health-and-economic-growth-in-asia-pacific-region

Medicare Monday: A guide to MedPAC’s Part B vote this week

PhRMA  |  Blog Post

The new program could also restrict patient access through new tools such as formularies and prior authorization.
http://catalyst.phrma.org/medicare-monday-a-guide-to-medpacs-part-b-vote-this-week

Strong IP is propelling innovation and saving lives

PhRMA  |  Blog Post

Patents, data protections and periods of exclusivity are the tools necessary to supporting future R&D investments and, in turn, the discoveries that will save the lives of tomorrow.
http://catalyst.phrma.org/strong-ip-is-propelling-innovation-and-saving-lives

Continuing and Expanding the Georgetown-PhRMA Fellowship Program

PhRMA  |  Blog Post

The Catalyst welcomes guest contributors including patients, stakeholders, innovators and others to share their perspectives and point of view.
http://catalyst.phrma.org/continuing-and-expanding-the-georgetown-phrma-fellowship-program

PhRMA Names Ieva M. Augstums as Deputy Vice President, Communications and Public Affairs

PhRMA  |  Press Release

PhRMA is all about innovations and discoveries that improve and extend the lives of people all over the world, and I can’t think of anything more rewarding to help communicate than that,” says Augstums.
https://www.phrma.org/press-release/phrma-names-ieva-m-augstums-as-deputy-vice-president-communications-and-public-affairs

Direct-to-consumer advertising makes doctors and patients stronger partners

PhRMA  |  Blog Post

And that’s a good thing for patients.
http://catalyst.phrma.org/direct-to-consumer-advertising-makes-doctors-and-patients-stronger-partners

PhRMA Honors Patient Advocates Ron and Raychel Bartek

PhRMA  |  Press Release

Industry-wide research and investment reached a record $65.2 billion in 2008.
https://www.phrma.org/press-release/phrma-honors-patient-advocates-ron-and-raychel-bartek

340B Program in urgent need of expanded Congressional and administrative oversight, reform

PhRMA  |  Press Release

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research and biotechnology companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives.
https://www.phrma.org/press-release/340b-program-in-urgent-need-of-expanded-congressional-and-administrative-oversight-reform

New Report Reveals Growth Trajectories and Top Policy Factors Affecting Biopharmaceutical Innovation & Growth

PhRMA  |  Press Release

About PhRMA The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research and biotechnology companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives.
https://www.phrma.org/press-release/new-report-reveals-growth-trajectories-and-top-policy-factors-affecting-biopharmaceutical-innovation-and-growth

PhRMA Names Rajesh Ranganathan, Ph.D. as Vice President of Science and Regulatory Advocacy

PhRMA  |  Press Release

“I am honored to join the team at PhRMA and contribute to their work with the many stakeholders in the biomedical ecosystem to advance drug discovery and development, regulatory sciences and productive collaborations,” said Dr.
https://www.phrma.org/press-release/phrma-names-rajesh-ranganathan-ph-d-as-vice-president-of-science-and-regulatory-advocacy

New PhRMA and Epilepsy Foundation Report: 420 Medicines in Development for Neurological Disorders

PhRMA  |  Blog Post

Get Medicines in Development reports and other issue updates here.
http://catalyst.phrma.org/new-phrma-and-epilepsy-foundation-report-420-medicines-in-development-for-neurological-disorders

Outdated FDA Regulations Discourage Development and Dissemination of Healthcare Economic Data to Support Value-Based Healthcare

PhRMA  |  Blog Post

This will reduce competition, and leave consumers, physicians, and the entities that purchase medicines with less information to inform their decisions.
http://catalyst.phrma.org/outdated-fda-regulations-discourage-development-and-dissemination-of-healthcare-economic-data-to-support-value-based-healthcare

Biopharmaceutical Research Companies Developing 92 Medicines to Treat Arthritis and Musculoskeletal Diseases

PhRMA  |  Blog Post

We look forward to hearing from the contributors and from you about how we can continue the progress in helping patients with arthritis and related diseases.
http://catalyst.phrma.org/biopharmaceutical-research-companies-developing-92-medicines-to-treat-arthritis-and-musculoskeletal-diseases

You have reviewed the first 300 results out of 2501. Each page contains 25 results. You're on page 12.

prev 7 8 9 10 11 12 next